Reese Jones, M.D.
Langley Porter Psychiatric Institute
5
5
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Gantt Galloway, PharmD
California Pacific Medical Center
Shared therapeutic areas:
Tracy Hellem, PhD
Montana State University
Shared therapeutic areas:
Boris B Quednow, Prof
Psychiatric University Hospital, Zurich
Shared therapeutic areas:
Thomas Newton, M.D.
National Institute on Drug Abuse (NIDA)
Shared therapeutic areas:
Worked with same sponsors:
Theresa Winhusen, Ph.D.
University of Cincinnati
Shared therapeutic areas:
Worked with same sponsors:
Magi Farre, MD, PhD
Parc de Salut Mar
Shared therapeutic areas:
Richard De La Garza, II, PhD
Baylor College of Medicine
Shared therapeutic areas:
Worked with same sponsors:
Perry F Renshaw, MD, PhD, MBA
University of Utah
Shared therapeutic areas:
Worked with same sponsors:
John Mendelson, MD
California Pacific Medical Center
Shared therapeutic areas:
Michael Mancino, MD
University of Arkansas
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1
Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1
A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1
Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1
All 5 trials loaded